Literature DB >> 2860216

Treatment of insulin excess by continuous subcutaneous infusion of somatostatin and glucagon in an infant.

P F Bougnères, F Landier, P Garnier, J C Job, J L Chaussain.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2860216     DOI： 10.1016/s0022-3476(85)80358-9

Source DB:  PubMed          Journal:  J Pediatr        ISSN： 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  7 in total

1.  Tolerance to somatostatin analogue in a preterm infant with islet cell dysregulation syndrome.

Authors:  J M Hawdon; M P Ward Platt; W H Lamb; A Aynsley-Green
Journal:  Arch Dis Child       Date:  1991-03       Impact factor: 3.791

2.  Hypoglycemic syndrome in infancy and childhood. A surgeon's perspective.

Authors:  A R Moossa; L Baker; M Lavelle-Jones
Journal:  West J Med       Date:  1987-05

3.  Pancreatic venous samplings in infants and children with primary hyperinsulinism.

Authors:  F Brunelle; V Negre; M O Barth; C N Fekete; P Czernichow; J M Saudubray; F Kuntz; T Tach; D Lallemand
Journal:  Pediatr Radiol       Date:  1989

4.  Hypertrophic obstructive cardiomyopathy in neonatal beta-cell adenoma of the pancreas.

Authors:  G Hausdorf; L Grävinghoff; T Rettig; H H Hellwege; E W Keck
Journal:  Pediatr Cardiol       Date:  1988       Impact factor: 1.655

5.  Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood.

Authors:  L Spitz; R K Bhargava; D B Grant; J V Leonard
Journal:  Arch Dis Child       Date:  1992-02       Impact factor: 3.791

Review 6.  Somatostatin analogues for the treatment of hyperinsulinaemic hypoglycaemia.

Authors:  Basma Haris; Saras Saraswathi; Khalid Hussain
Journal:  Ther Adv Endocrinol Metab       Date:  2020-12-02       Impact factor: 3.565

Review 7.  Somatostatin receptors in congenital hyperinsulinism: Biology to bedside.

Authors:  Mirjam E van Albada; Klaus Mohnike; Mark J Dunne; Indi Banerjee; Stephen F Betz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.